Tag: Fisher & Paykel Healthcare
Product launches: Fisher & Paykel Healthcare, Sunrise Medical, Medbill
November 15, 2024HME News Staff
Auckland, New Zealand-based Fisher & Paykel Healthcare has launched the F&P Nova Mico nasal pillows mask for the treatment of obstructive sleep apnea in the U.S. Weighing less than 1.4 ounces, the new mask features minimal, easy adjusting headgear and a soft MicroPillows cushion that nestles gently within the nostrils and inflates to conform to the patient’s nose, providing stability and freedom of movement. “The Nova Micro is another strong addition to our mask portfolio, and we are...
F&P issues half, full-year 2025 guidance
August 27, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has released guidance of revenue in the range of approximately $940 million to $950 million for the first half of its 2025 financial year, which ends Sept. 30, 2024. Full 2025 financial year guidance is expected to be in the range of approximately $1.9 billion to $2.0 billion, with full year net profit after tax to be in the range of approximately $320 million to $370 million. “The year to date has begun strongly across all products and...
F&P fills board seat
August 20, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has appointed Mark Cross to the board as a non-executive director effective Oct. 1. Cross, who currently chairs the board of Chorus, where he has been a director since 2016, replaces Scott St. John, who will retire from the board at the end of August. “Mark is a strategic thinker who understands the technology and innovation sector and brings a fresh perspective,” said St. John. “With strong business acumen and a background...
In brief: Owens & Minor earnings, DMEscripts integration, F&P launch
August 2, 2024HME News Staff
RICHMOND, Va. – Owens & Minor reported consolidated revenue of $2.7 billion for the second quarter of 2024, an increase of 4% year over year.
Of that, Patient Direct revenue was $660 million, an increase of 4%, driven by continued strong growth in diabetes and sleep supplies.
“Our Patient Direct segment performed in line with our expectations, and we expect the segment to benefit from seasonality and recent organic investments during the back half of the year,”...
F&P launches all-in-one humidifier
August 1, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has launched a new platform in the U.S. that is able to provide humidification for all vent applications in one system. The F&P my820 provides heated humidification during the delivery of invasive ventilation, noninvasive ventilation and humidified high-flow therapies for adult and pediatric patients. “The F&P my820 is the result of years of dedicated investment in new technologies that improve care and outcomes for patients in their...
F&P sees steadier growth for CPAP masks
May 31, 2024Liz Beaulieu, Editor
AUCKLAND, New Zealand – Now that the step-up in patient starts for sleep therapy has “probably washed through the previous year,” Fisher & Paykel Healthcare expects to maintain CPAP mask growth of about 10%, says CEO Lewis Gradon.
The company previously reported a 28% increase in revenue in constant currency terms for masks in the first half of financial year 2024, benefitting from significant progress in reducing a backlog of patients seeking therapy, but Gradon previously...
In brief: HoneyNaps funding, Philips BiPAP update, F&P Healthcare results
May 29, 2024HME News Staff
BOSTON – HoneyNaps, an AI sleep data analysis company based in South Korea, has closed its series B round of funding, securing $11.6 million.
This funding is nearly three times the $3.9 million raised through series A funding back in 2021.
"This successful funding amidst a challenging investment climate has validated our position as Korea's leading sleep-tech company,” the company’s CFO stated in a press release. "These resources will enable us to...
F&P Healthcare ‘returned to trajectory of growth’
May 29, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has reported total operating revenue of $1.74 billion for the 2024 financial year, a 10% increase year over year, or 8% in constant currency.
The company says its growth was driven by solid demand in hospital consumables and strong growth in the obstructive sleep apnea mask business.
“After several years of changing demand patterns, we are pleased to have returned to a trajectory of growth,” said CEO Lewis Gradon....
F&P launches AutoFit segment
April 25, 2024HME News Staff
IRVINE, Calif. – Fisher & Paykel Healthcare hosted a webinar this week to highlight the launch of its F&P Solo Nasal mask in the U.S. The company says the AutoFit mask is the first to allow users to stretch it onto their face and adjust it with one touch. “F&P Solo Nasal marks the creation of our AutoFit segment, and our teams have delivered a significant leap in mask innovation, driven by the unwavering commitment to enhance patient outcomes,” said Justin Callahan, vice president...
Product launches: Pride Mobility, Fisher & Paykel
April 9, 2024HME News Staff
Pride Mobility Products has launched the Go Go Elite Traveller 2 4-Wheel, a scooter that it says has the tightest turning radius of any four-wheel scooter on the market. The scooter features iTurn Technology, offering four-wheel stability with three-wheel maneuverability. It also features interchangeable red and black shrouds that come standard with six additional colors available, two battery options and a weight capacity of 300 pounds and a top speed of 4 mph. FMI: https://www.pridemobility.com/go-go-travel-mobility/go-go-elite-traveller-2-4-wheel/.
Fisher...